CA2107329A1 - Anticorps recombinants anti-virus de l'immunodeficience humaine - Google Patents

Anticorps recombinants anti-virus de l'immunodeficience humaine

Info

Publication number
CA2107329A1
CA2107329A1 CA2107329A CA2107329A CA2107329A1 CA 2107329 A1 CA2107329 A1 CA 2107329A1 CA 2107329 A CA2107329 A CA 2107329A CA 2107329 A CA2107329 A CA 2107329A CA 2107329 A1 CA2107329 A1 CA 2107329A1
Authority
CA
Canada
Prior art keywords
immunodeficiency virus
human immunodeficiency
recombinant antibodies
virus recombinant
combining site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2107329A
Other languages
English (en)
Other versions
CA2107329C (fr
Inventor
Bona Constantin
Zaghouani Habib
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2107329A1 publication Critical patent/CA2107329A1/fr
Application granted granted Critical
Publication of CA2107329C publication Critical patent/CA2107329C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention décrit des anticorps hybrides comprenant une partie de base correspondant à la partie constante de l'immunoglobuline G chez l'homme, un site de combinaison sélectionné pour sa spécificité à l'antigène cible particulier et un site de combinaison se fixant aux lymphocytes T cytotoxiques humains et activant ceux-ci.
CA002107329A 1991-04-18 1992-04-10 Anticorps recombinants anti-virus de l'immunodeficience humaine Expired - Fee Related CA2107329C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68737691A 1991-04-18 1991-04-18
US07/687,376 1991-04-18
PCT/US1992/002975 WO1992018540A1 (fr) 1991-04-18 1992-04-10 Anticorps recombines anti-vih

Publications (2)

Publication Number Publication Date
CA2107329A1 true CA2107329A1 (fr) 1992-10-19
CA2107329C CA2107329C (fr) 1999-04-27

Family

ID=24760226

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002107329A Expired - Fee Related CA2107329C (fr) 1991-04-18 1992-04-10 Anticorps recombinants anti-virus de l'immunodeficience humaine

Country Status (6)

Country Link
EP (1) EP0580758A4 (fr)
JP (1) JPH06506947A (fr)
AU (1) AU672580B2 (fr)
CA (1) CA2107329C (fr)
IL (1) IL101602A (fr)
WO (1) WO1992018540A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0460076T3 (da) * 1989-02-24 1996-03-25 Univ California Genetisk manipulerede immunoglobuliner
US5969109A (en) * 1990-02-28 1999-10-19 Bona; Constantin Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
GB0102145D0 (en) * 2001-01-26 2001-03-14 Scancell Ltd Substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3850542T2 (de) * 1987-09-23 1994-11-24 Bristol Myers Squibb Co Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen.
WO1993019180A1 (fr) * 1992-03-17 1993-09-30 Ciba-Geigy Ag Anticorps produits par genie genetique
EP0570357B1 (fr) * 1992-05-14 1997-06-25 Polymun Scientific Immunbiologische Forschung GmbH Peptides induisant des anticorps, qui neutralisent des isolées d'HIV-1 qui divergent génétiquement

Also Published As

Publication number Publication date
EP0580758A1 (fr) 1994-02-02
CA2107329C (fr) 1999-04-27
AU1891992A (en) 1992-11-17
IL101602A0 (en) 1992-12-30
IL101602A (en) 1996-10-31
AU672580B2 (en) 1996-10-10
EP0580758A4 (fr) 1995-04-05
WO1992018540A1 (fr) 1992-10-29
JPH06506947A (ja) 1994-08-04

Similar Documents

Publication Publication Date Title
CA2149120A1 (fr) Anticorps monoclonal se liant specifiquement a l'endothelium vasculaire tumoral et utilisations de cette substance
IL83113A (en) Bifunctional antibodies having antigen specificity for fc receptor and for an epitope of a target cell
WO1994029451A3 (fr) Anticorps humanises
CA2025597A1 (fr) Vaccin contre la maladie de lyme
CA2118010A1 (fr) Anticorps specifiques des antigenes associes a un carcinome
TNSN93012A1 (fr) Conception, clonage et expression d'anticorps monoclonaux humanises contre l'interleukine-5 humaine
WO1994004691A3 (fr) Formes dimeres et multimeres de polypeptides monocatenaires
AU4230493A (en) Diphtheria toxin receptor-binding region
EP1266965A3 (fr) Anticorps de recombinaison pour thérapie humaine
WO1999003987A3 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
CA2109815A1 (fr) Preparation d'anticorps
AU2042992A (en) Seroreactive regions on hpv 16 proteins e1 and e2
AU628948B2 (en) Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof
AU676859B2 (en) Synthetic peptides, antibodies against them and their use
EP1860188A3 (fr) Récepteur de cytokine humain
CA2091263A1 (fr) Peptides utilises pour la vaccination et l'induction d'anticorps neutralisants contre le virus de l'immunodeficience humaine
EP1350799A3 (fr) Polypeptides d'immunoglobulines inhibiteurs se liant au récepteur-beta humain de PDGF
CA2055615A1 (fr) Anticorps monoclonaux pour induire la toterance
DE3650032D1 (de) Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
WO2003048194A3 (fr) Peptide ou proteine contenant une boucle c'-d de la famille de recepteurs cd28
AU7203194A (en) Bispecific human monoclonal antibodies specific for human immunodeficiency virus
ATE211148T1 (de) Hcmv-spezifische peptide und ihre verwendung
AU1423892A (en) Monoclonal antibodies directed towards mycobacterial antigens
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
CA2070182A1 (fr) Immunoglobuline chimerique pour recepteurs cda

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed